• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腋窝多汗症——氯化铝止汗剂的疗效和耐受性。对20例特发性腋窝多汗症患者的前瞻性评估]

[Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis].

作者信息

Streker M, Reuther T, Verst S, Kerscher M

机构信息

Studiengang Kosmetikwissenschaft (FB 13), Universität Hamburg.

出版信息

Hautarzt. 2010 Feb;61(2):139-44. doi: 10.1007/s00105-009-1841-y.

DOI:10.1007/s00105-009-1841-y
PMID:19953218
Abstract

BACKGROUND

The purpose of this study was to evaluate the efficacy and tolerability of aluminium chloride gel for treatment of axillary hyperhidrosis.

PATIENTS AND METHODS

A total of 20 patients aged 22-38 (mean age: 26.9+/-4.3) with idiopathic axillary hyperhidrosis were included and treated with an antiperspirant (Sweat-off, Sweat-off GmbH, Hügelsheim). Study duration was 42 days. Treatment efficacy was evaluated clinically, as well as by starch-iodine test, gravimetric analysis and evaluation of the skin surface pH.

RESULTS

After treatment there was a significant clinical improvement accompanied by significant qualitative and quantitative reduction of sweat as well as a significant reduction of skin surface pH. Except for slight skin irritation in 6 patients, there were no other side effects. Patient satisfaction improved markedly during the study.

CONCLUSION

Treatment of axillary hyperhidrosis with aluminium chloride is an effective, safe and inexpensive treatment modality.

摘要

背景

本研究旨在评估氯化铝凝胶治疗腋窝多汗症的疗效和耐受性。

患者与方法

共纳入20例年龄在22 - 38岁(平均年龄:26.9±4.3)的特发性腋窝多汗症患者,使用一种止汗剂(Sweat-off,Sweat-off GmbH,许格尔斯海姆)进行治疗。研究持续时间为42天。通过临床评估、淀粉碘试验、重量分析以及皮肤表面pH值评估来评价治疗效果。

结果

治疗后临床症状有显著改善,同时汗液的质和量均显著减少,皮肤表面pH值也显著降低。除6例患者有轻微皮肤刺激外,无其他副作用。在研究过程中患者满意度明显提高。

结论

用氯化铝治疗腋窝多汗症是一种有效、安全且廉价的治疗方式。

相似文献

1
[Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis].[腋窝多汗症——氯化铝止汗剂的疗效和耐受性。对20例特发性腋窝多汗症患者的前瞻性评估]
Hautarzt. 2010 Feb;61(2):139-44. doi: 10.1007/s00105-009-1841-y.
2
Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride.足底多汗症——一种止汗剂的随机、半侧试验,评估不同浓度氯化铝的疗效和安全性。
J Dtsch Dermatol Ges. 2012 Feb;10(2):115-9. doi: 10.1111/j.1610-0387.2011.07750.x. Epub 2011 Aug 16.
3
Comparison of a novel aluminum lactate-based with an aluminum chloride-based antiperspirant in excessive axillary and inguinal perspiration: first randomized controlled trial.新型乳酸铝制剂与氯化铝制剂止汗剂治疗过度腋窝和腹股沟多汗的比较:首个随机对照试验。
J Dtsch Dermatol Ges. 2022 Dec;20(12):1589-1601. doi: 10.1111/ddg.14898. Epub 2022 Dec 10.
4
An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.一项关于15%氯化铝于2%水杨酸凝胶基质中治疗中重度原发性腋窝多汗症疗效的开放标签试验。
J Drugs Dermatol. 2009 May;8(5):477-80.
5
Axillary hyperhidrosis. Local treatment with aluminium-chloride hexahydrate 25% in absolute ethanol with and without supplementary treatment with triethanolamine.腋窝多汗症。采用含25%六水合氯化铝的无水乙醇进行局部治疗,同时进行或不进行三乙醇胺辅助治疗。
Acta Derm Venereol. 1988;68(1):87-9.
6
Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panelists.临床研究表明,一种非处方的软固态止汗剂可以减少出汗量,并与男性志愿者使用的处方止汗剂产品进行了比较。
Br J Dermatol. 2012 Mar;166 Suppl 1:22-6. doi: 10.1111/j.1365-2133.2011.10786.x.
7
Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: A randomized controlled trial.20%倍半氯化铝与20%氯化铝治疗腋窝多汗症的疗效和耐受性:一项随机对照试验。
Dermatol Ther. 2020 Nov;33(6):e14354. doi: 10.1111/dth.14354. Epub 2020 Oct 10.
8
Reversibility of hyperhidrosis post axillary depilatory laser.腋窝脱毛激光治疗后多汗症的可逆性
Lasers Med Sci. 2014 Mar;29(2):717-21. doi: 10.1007/s10103-013-1404-4. Epub 2013 Jul 26.
9
Topical pharmacological treatment.局部药物治疗。
Curr Probl Dermatol. 2002;30:30-43. doi: 10.1159/000060693.
10
[Antiperspirants for the therapy of focal hyperhidrosis].[用于治疗局限性多汗症的止汗剂]
Hautarzt. 2012 Jun;63(6):452-5. doi: 10.1007/s00105-012-2330-2.

引用本文的文献

1
Treatment of Hyperhidrosis: An Update.多汗症的治疗:最新进展。
Am J Clin Dermatol. 2022 Sep;23(5):635-646. doi: 10.1007/s40257-022-00707-x. Epub 2022 Jul 1.
2
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.对药物、职业和消费者接触金属及纳米级铝、氧化铝、氢氧化铝及其可溶性盐所带来的潜在健康风险的系统评价。
Crit Rev Toxicol. 2014 Oct;44 Suppl 4(Suppl 4):1-80. doi: 10.3109/10408444.2014.934439.
3
[Antiperspirants for the therapy of focal hyperhidrosis].

本文引用的文献

1
An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis.倍半氯化铝外用泡沫治疗腋窝和手掌原发性多汗症的开放标签耐受性和疗效研究。
Dermatol Ther. 2008 Jul;21 Suppl 1:S27-30. doi: 10.1111/j.1529-8019.2008.00199.x.
2
Definition and treatment of primary hyperhidrosis.原发性多汗症的定义与治疗
J Dtsch Dermatol Ges. 2007 Jul;5(7):625-8. doi: 10.1111/j.1610-0387.2007.06409.x.
3
Hyperhidrosis: evolving therapies for a well-established phenomenon.多汗症:针对一种常见现象的不断发展的治疗方法。
[用于治疗局限性多汗症的止汗剂]
Hautarzt. 2012 Jun;63(6):452-5. doi: 10.1007/s00105-012-2330-2.
Mayo Clin Proc. 2005 May;80(5):657-66. doi: 10.4065/80.5.657.
4
Current therapeutic options for treating primary hyperhidrosis.治疗原发性多汗症的当前治疗选择。
Eur J Vasc Endovasc Surg. 2004 Jun;27(6):571-6. doi: 10.1016/j.ejvs.2004.01.023.
5
Evidence-based medicine and the treatment of hyperhidrosis.循证医学与多汗症的治疗
J Am Acad Dermatol. 2004 Feb;50(2):327-8; author reply 328. doi: 10.1016/s0190-9622(03)02085-1.
6
Evidence-based medicine: botulinum toxin in focal hyperhidrosis.循证医学:肉毒杆菌毒素治疗局限性多汗症
J Neurol. 2001 Apr;248 Suppl 1:31-3. doi: 10.1007/pl00007817.
7
Botulinum toxin A for axillary hyperhidrosis (excessive sweating).A型肉毒杆菌毒素治疗腋窝多汗症(出汗过多)。
N Engl J Med. 2001 Feb 15;344(7):488-93. doi: 10.1056/NEJM200102153440704.
8
Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in application.用于局限性多汗症的肉毒杆菌毒素:技术考量与应用改进
Br J Dermatol. 1998 Dec;139(6):1123-4. doi: 10.1046/j.1365-2133.1998.2576k.x.
9
Palmoplantar hyperhidrosis. Treatment with alcohol solution of aluminium chloride hexahydrate: a simple method of transpiration measurement.掌跖多汗症。用六水合氯化铝酒精溶液治疗:一种简单的排汗测量方法。
Dermatologica. 1980;161(2):133-5.
10
Axillary hyperhidrosis, 20% aluminum chloride hexahydrate, and surgery.腋窝多汗症、20%六水合氯化铝与手术
Br Med J. 1980 May 10;280(6224):1168. doi: 10.1136/bmj.280.6224.1168.